Aceon
(Perindopril)ApprovedSmall molecule
Institut de Recherches Internationales ServierPerindopril is used to treat high blood pressure and to help the heart work more efficiently after a heart attack or in heart failure. It works by relaxing blood vessels to allow blood to flow more easily.[2] Aceon is currently approved and in use across 17 indications[4].[1]
Aceon is one of 382 small molecule programs targeting Childhood Cancer. It is currently in Approved.
17
Indications
27
Total Trials
1
Active Trials
381
Competitors
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 17 indications
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Aceon
Institut de Recherches Internationales ServierApproved
Cymbalta
Alnylam PharmaceuticalsPreclinical
Methylthioninium Chloride
PProvepharm SAS
Preclinical
Paracetamol
GSKPreclinical
Neoadjuvant Therapy
SSun Yat-sen University
Preclinical
Motexafin Gadolinium
PPharmacyclics LLC.
Preclinical
Bisphosphonate
AmgenPreclinical
Perflutren Lipid Microcpheres
TThomas Jefferson University
Preclinical
Tianeptine
PfizerPreclinical
Ablavar
LLantheus Medical Imaging
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Hypertension5 trials
Blood Pressure2 trials
Angiotensin Converting Enzyme2 trials
Hematoma1 trial
16 more indications
Dilated Cardiomyopathy1 trial
PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Terminated·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 3·NCT01583114·6 enrolled
Chronic Kidney Disease1 trial
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
Unknown status·—·Phase 4·NCT02299310·60 enrolled
PTSD1 trial
DOXAZOSIN FOR PTSD
Completed·—·Phase 1·NCT02308202·30 enrolled
Essential Hypertension1 trial
Methamphetamine Dependence1 trial
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Completed·—·Phase 1·NCT01062451·80 enrolled
Marfan syndrome1 trial
Comparison of Medical Therapies in Marfan Syndrome.
Completed·—·Phase 4·NCT01295047·18 enrolled
Cerebral Small Vessel Disease1 trial
Body Weight1 trial
Fasting Conditions1 trial
Type 2 Diabetes1 trial
Alcoholic Fatty Liver Disease1 trial
Unspecified1 trial
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Aceon drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Perindopril. EMBL-EBI & Wellcome Sanger Institute.
- [5]
Details